Health Canada tweeted Tuesday that it expects to reach a decision by mid-July on whether to approve Moderna’s vaccine for children between six months and five years of age.
Moderna applied for its vaccine to be given in two doses, each a quarter of its adult dose, about four weeks apart.
The agency says it received a submission from Pfizer-BioNTech on June 23 for its vaccine for children between the ages of six months and four years.
A Health Canada spokesman says regulators are still working out a timeline for reviewing Pfizer-BioNTech’s application.
Canada has yet to approve a vaccine for nearly two million children under five.
Pfizer-BioNTech’s Comirnaty vaccine can be used in children up to five years of age, and Moderna’s Spikevax vaccine is approved for children six years of age and older.
This report by The Canadian Press was first published on July 5, 2022.
